WDSUB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.391600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.567400E-01
Normal-vs-Stage2
1.869350E-01
Normal-vs-Stage3
3.515900E-03
Normal-vs-Stage4
8.579000E-01
Stage1-vs-Stage2
5.098600E-01
Stage1-vs-Stage3
4.147900E-02
Stage1-vs-Stage4
3.708800E-01
Stage2-vs-Stage3
1.485020E-01
Stage2-vs-Stage4
6.920200E-02
Stage3-vs-Stage4
1.104630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.336200E-01
Normal-vs-AfricanAmerican
1.929240E-01
Normal-vs-Asian
4.966200E-01
Caucasian-vs-AfricanAmerican
5.703400E-01
Caucasian-vs-Asian
9.254200E-01
AfricanAmerican-vs-Asian
7.119000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.587610E-01
Normal-vs-Female
3.372600E-01
Male-vs-Female
6.529600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.605570E-01
Normal-vs-Age(41-60Yrs)
3.437200E-01
Normal-vs-Age(61-80Yrs)
2.095600E-01
Normal-vs-Age(81-100Yrs)
2.414400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.804200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.068000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.716200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.664200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.312400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.785400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.865640E-01
Normal-vs-Daily Drinker
9.620400E-02
Normal-vs-Weekly Drinker
2.991400E-01
Normal-vs-Occasional Drinker
8.797400E-01
Normal-vs-Social Drinker
1.056550E-01
Non Drinker-vs-Daily Drinker
8.631800E-01
Non Drinker-vs-Weekly Drinker
7.836200E-01
Non Drinker-vs-Occasional Drinker
4.913500E-02
Non Drinker-vs-Social Drinker
9.328800E-01
Daily Drinker-vs-Weekly Drinker
6.673600E-01
Daily Drinker-vs-Occasional Drinker
4.859600E-02
Daily Drinker-vs-Social Drinker
9.411400E-01
Weekly Drinker-vs-Occasional Drinker
1.838570E-01
Weekly Drinker-vs-Social Drinker
7.408400E-01
Occasional Drinker-vs-Social Drinker
7.555800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.752200E-02
Normal-vs-Grade 2
9.997600E-03
Normal-vs-Grade 3
1.570040E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.348000E-01
Grade 1-vs-Grade 3
7.270000E-01
Grade 1-vs-Grade 4
4.752200E-02
Grade 2-vs-Grade 3
5.396400E-01
Grade 2-vs-Grade 4
9.997600E-03
Grade 3-vs-Grade 4
1.570040E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.645800E-01
Normal-vs-NonDiabetic
2.580000E-01
Diabetic-vs-NonDiabetic
3.837400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.200100E-02
Normal-vs-NoPancreatitis
2.919000E-01
Pancreatitis-vs-NoPancreatitis
1.711020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.563000E-01
Normal-vs-N1
2.020600E-01
N0-vs-N1
6.252600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.025000E-01
Normal-vs-TP53-NonMutant
4.536400E-01
TP53-Mutant-vs-TP53-NonMutant
3.253600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
